Detalhe da pesquisa
1.
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells.
Biol Blood Marrow Transplant
; 26(1): 26-33, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31419568
2.
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy.
Br J Haematol
; 189(6): 1119-1126, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030732
3.
Urinary cross-linked carboxyterminal telopeptide, a bone resorption marker, decreases after vaso-occlusive crises in adults with sickle cell disease.
Blood Cells Mol Dis
; 80: 102369, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31677454
4.
Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up.
Clin Lymphoma Myeloma Leuk
; 24(2): e33-e39.e1, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926672
5.
Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3' untranslated region mutations.
Cell Rep
; 42(8): 112840, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516102
6.
Outcomes Among Homeless Patients With Non-Small-Cell Lung Cancer: A County Hospital Experience.
JCO Oncol Pract
; 16(9): e1004-e1014, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525753
7.
Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
Clin Breast Cancer
; 18(1): e143-e149, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174203
8.
Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma.
Blood Cancer J
; 9(10): 77, 2019 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570697